From CLL to Multiple Myeloma - Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration

被引：7
|
作者：
Lorenz, Joschka [1 ]
Waldschmidt, Johannes [1 ]
Wider, Dagmar [1 ]
Follo, Marie [1 ]
Ihorst, Gabriele [2 ]
Chatterjee, Manik [3 ]
May, Annette M. [4 ]
Duyster, Justus [1 ]
Rosenwald, Andreas [5 ]
Waesch, Ralph [1 ]
Zirlik, Katja [1 ]
Engelhardt, Monika [1 ]
机构：
[1] Univ Med Ctr Freiburg, Dept Haematol Oncol & Stem Cell Transplantat, Freiburg, Germany
[2] Univ Med Ctr Freiburg, Clin Trials Ctr, Freiburg, Germany
[3] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany
[4] Univ Freiburg Med Ctr, Inst Pathol, Freiburg, Germany
[5] Univ Hosp Wurzburg, Inst Pathol, Wurzburg, Germany
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2016年 / 174卷 / 06期
关键词：
multiple myeloma; chronic lymphocytic leukemia; spleen tyrosine kinase; R406; therapy; CHRONIC LYMPHOCYTIC-LEUKEMIA; INHIBITION;
D O I：
10.1111/bjh.13825
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：985 / 989
页数：6
相关论文
共 50 条
  • [21] Protein tyrosine phosphatases in multiple myeloma
    Abdollahi, Pegah
    Koehn, Maja
    Borset, Magne
    CANCER LETTERS, 2021, 501 : 105 - 113
  • [22] Mer Receptor Tyrosine Kinase Is a Novel Therapeutic Target In Multiple Myeloma
    Christoph, Sandra
    Maag, Silks
    DeRyckere, Deborah
    Graham, Douglas K.
    Frye, Stephen V.
    Earp, H. Shelton, III
    Liu, Jing
    Yang, Chao
    Zhang, Weihe
    Wang, Xiaodong
    Elmaagacli, Ahmet H.
    Beelen, Dietrich
    BLOOD, 2013, 122 (21)
  • [23] Bruton's tyrosine kinase: potential target in human multiple myeloma
    Liu, Ying
    Dong, Ying
    Jiang, Qian-Li
    Zhang, Bo
    Hu, An-Mei
    LEUKEMIA & LYMPHOMA, 2014, 55 (01) : 177 - 181
  • [24] Integrin β7-Mediated Regulation of Multiple Myeloma Cell Adhesion, Migration and Survival
    Neri, Paola
    Ren, Li
    Gratton, Kathy
    Klimowicz, Alex
    Mansoor, Adnan
    Stewart, Douglas A.
    Bahlis, Nizar J.
    BLOOD, 2009, 114 (22) : 392 - 392
  • [25] A novel dual inhibitor of microtubule and Bruton's tyrosine kinase inhibits survival of multiple myeloma and osteoclastogenesis
    Pandey, Manoj K.
    Gowda, Krishne
    Sung, Shen-shu
    Abraham, Thomas
    Budak-Alpdogan, Tulin
    Talamo, Giampolo
    Dovat, Sinisa
    Amin, Shantu
    EXPERIMENTAL HEMATOLOGY, 2017, 53 : 31 - 42
  • [26] RalA mediates cell survival effects in multiple myeloma
    Steinbrunn, T.
    Stuehmer, T.
    Mottok, A.
    Rosenwald, A.
    Chatterjee, M.
    Einsele, H.
    Bargou, R. C.
    ONKOLOGIE, 2013, 36 : 149 - 149
  • [27] Marital Status and Survival in Patients with Multiple Myeloma: The Role of Marriage in the Management of Multiple Myeloma
    Islam, Serajul
    Lee, Chansoon
    Kim, Jichan
    Enright, Robert
    Kotoucek, Pavel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E259 - E260
  • [28] Impact of connexin 43 coupling on survival and migration of multiple myeloma cells
    Zhang, Yangmin
    Wang, Ziyan
    Zhang, Liying
    Zhou, Dongming
    Sun, Yu
    Wang, Panjun
    Ju, Songguang
    Chen, Ping
    Li, Jun
    Fu, Jinxiang
    ARCHIVES OF MEDICAL SCIENCE, 2017, 13 (06) : 1335 - 1346
  • [29] Bruton Tyrosine Kinase Is a Therapeutic Target in Stem-like Cells from Multiple Myeloma
    Yang, Ye
    Shi, Jumei
    Gu, Zhimin
    Salama, Mohamed E.
    Das, Satyabrata
    Wendlandt, Erik
    Xu, Hongwei
    Huang, Junwei
    Tao, Yi
    Hao, Mu
    Franqui, Reinaldo
    Levasseur, Dana
    Janz, Siegfried
    Tricot, Guido
    Zhan, Fenghuang
    CANCER RESEARCH, 2015, 75 (03) : 594 - 604
  • [30] Sphingosine kinase 2 and multiple myeloma
    Pyne, Nigel J.
    Pyne, Susan
    ONCOTARGET, 2017, 8 (27): : 43596 - 43597
12345